Document is current
Any future updates will be listed below
-
Authors
Lagger, Cyril https://orcid.org/0000-0003-1701-6896
Ursu, Eugen https://orcid.org/0000-0003-0788-7831
Equey, Anaïs
Avelar, Roberto A.
Pisco, Angela Oliveira https://orcid.org/0000-0003-0142-2355
Tacutu, Robi https://orcid.org/0000-0001-5853-2470
de Magalhães, João Pedro https://orcid.org/0000-0002-6363-2465
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/R014949/1)
Human Frontier Science Program (LT000741/2019-C)
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 27 September 2023
First Online: 2 November 2023
Competing interests
: J.P.d.M. is Chief Scientific Officer of YouthBio Therapeutics, an advisor/consultant for the Longevity Vision Fund, 199 Biotechnologies and NOVOS and the founder of Magellan Science Ltd., a company providing consulting services in longevity science. The remaining authors declare no competing interests.
